FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Senator Targets Firms Over Improper Patents

U.S. Senator Tammy Baldwin (D-WI) writes the four biggest drug companies marketing asthma inhalers urging them to stop unfairly blocking generics from...

latest-news-card-1
Human Drugs

Positive Data in Keytruda Kidney Cancer Trial

Merck says its Phase 3 KEYNOTE-564 trial evaluating Keytruda (pembrolizumab) as an adjuvant treatment in patients with renal cell carcinoma saw an imp...

latest-news-card-1
Medical Devices

Philips Respironics, FDA Reach Consent Decree

Philips Respironics and FDA reach an agreement on the terms of a consent decree over the companys struggles to resolve issues surrounding its troubled...

latest-news-card-1
Human Drugs

Human Genome Editing Product Development Guide

FDA issues a guidance entitled Human Gene Therapy Products Incorporating Human Genome Editing.

latest-news-card-1
Medical Devices

De Novo OK for Google Phone Thermometer

FDA grants Google a de novo marketing authorization for its new body temperature app on its latest Pixel 8 Pro smart phone.

latest-news-card-1
Human Drugs

Postmarketing Drug Surveillance Best Practices

FDA releases a document entitled Best Practices for FDA Staff in the Postmarketing Safety Surveillance of Human Drug and Biological Products.

latest-news-card-1
Medical Devices

FDA Should Identify AI Legislative Changes: GAO

A new GAO reports recommends that FDA identify and document specific changes to its statutory authorities that would enable it to best oversee artific...

latest-news-card-1
Human Drugs

ICH Guide on Analytical Procedure Development

The International Council for Harmonization releases a guidance entitled Q14 Guideline on Analytical Procedure Development.

latest-news-card-1
Human Drugs

Remote Regulatory Assessments Draft Guide

FDA makes available a revised draft guidance entitled Conducting Remote Regulatory Assessments (RRA) Questions and Answers.

latest-news-card-1
Federal Register

Vaccines/Biologics Advisory Committee Renewal

Federal Register notice: FDA announces the renewal of its Vaccines and Related Biological Products Advisory Committee for an additional two years.